AlectinibTransformation of lung adenocarcinoma to non-small cell lung cancer following alectinib resistance : case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1765卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65776-6

中图分类号：

学科分类号：

摘要：

引用

页码：19 / 19

共 50 条

[21] OsimertinibAcquired drug resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1721 (1) : 226 - 226
[22] Erlotinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2020, 1811 (1) : 123 - 123
[23] Carboplatin/paclitaxelAcquired drug resistance and transformation of non-small cell lung cancer to small cell lung cancer: case report
Reactions Weekly, 2020, 1804 (1) : 88 - 88
[24] GefitinibDevelopment of resistance in lung adenocarcinoma transforming to small cell lung cancer: case report
Reactions Weekly, 2017, 1659 (1) : 135 - 135
[25] Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report
Yang, Zhengyuan
Lin, Yingcheng
Wang, Hongbiao
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (08)
[26] Alectinib-associated pneumoperitoneum in stage IV non-small cell lung cancer- A case report
Maina, Renee M.
Rader, Caroline A.
Muenyi, Clarisse S.
Battini, Ramakrishna
Zalamea, Nia N.
Foretia, Denis A.
ANNALS OF MEDICINE AND SURGERY, 2022, 82
[27] AtezolizumabHyperprogression of non-small cell lung cancer: case report
Reactions Weekly, 2020, 1789 (1) : 52 - 52
[28] Case report: Hypereosinophilia in non-small cell lung cancer
Kwon, Hyunwoo
Li, Mingjia
Sheldon, Jesse D.
Jones, Nicholas
Crestani, Nicolas Gallastegui
Li, Zihai
Owen, Dwight H.
CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2024, 13
[29] PembrolizumabHyperprogression of non-small cell lung cancer: case report
Reactions Weekly, 2020, 1828 (1) : 411 - 411
[30] PembrolizumabHyperprogression of non-small cell lung cancer : case report
Reactions Weekly, 2024, 2020 (1) : 379 - 379

← 1 2 3 4 5 →